1.
GBD 2016 DALYs and HALE Collaborators. Global, regional, andnational disability-adjusted life-years (DALYs) for 333 diseasesand injuries and healthy life expectancy (HALE) for 195 countriesand territories, 1990-2016: a systematic analysis for the GlobalBurden of Disease Study 2016. Lancet. 2017;390(10100):1260-1344.
2.
Gibson CM. Has my patient achieved adequate myocardialreperfusion?. Circulation. 2003;108(5):504-507.
3.
Khan AR, Golwala H, Tripathi A, et al. Impact of totalocclusion of culprit artery in acute non-ST elevation myocardialinfarction: a systematic review and meta-analysis. Eur Heart J.2017;38(41):3082-3089.
4.
Ibánez B, James S, Agewall S, et al. 2017 ESC Guidelines for themanagement of acute myocardial infarction in patients presentingwith ST-segment elevation. Rev Esp Cardiol. 2017;70(12):1082.
5.
Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A. Role ofinflammation in atherosclerosis. J Nucl Med. 2007;48(11):1800-1815.
6.
Murphy AJ, Woollard KJ, Suhartoyo A, et al. Neutrophil activationis attenuated by high-density lipoprotein and apolipoproteinA-I in in vitro and in vivo models of inflammation. ArteriosclerThromb Vasc Biol. 2011;31(6):1333-1341.
7.
Hafiane A, Genest J. High density lipoproteins: Measurementtechniques and potential biomarkers of cardiovascular risk. BBAClin. 2015; 3:175-188.
8.
Chen Y, Jiang D, Tao H, Ge P, Duan Q. Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic markerin patients with ST-segment elevation myocardial infarctionundergoing primary percutaneous coronary intervention: aretrospective study. BMC Cardiovasc Disord. 2022;22(1):434.
9.
Gkantzios A, Tsiptsios D, Karapepera V, et al. Monocyte toHDL and neutrophil to HDL ratios as potential ischemic strokeprognostic biomarkers. Neurol Int. 2023;15(1):301-317.
10.
Kou T, Luo H, Yin L. Relationship between neutrophils to HDL-Cratio and severity of coronary stenosis. BMC Cardiovasc Disord.2021;21(1):127.
11.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definitionof myocardial infarction (2018). Circulation. 2018;138(20):e618-e651.
12.
TIMI Study Group. The Thrombolysis in Myocardial Infarction(TIMI) trial. Phase I findings. N Engl J Med. 1985;312(14):932-936.
13.
Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographiccorrelates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primarypercutaneous coronary intervention. J Am Coll Cardiol.2003;42(10):1739-1746.
14.
Doganay B, Okutucu S, Cetin M, et al. Association of serumcopeptin levels with patency of infarct-related arteries in patientswith ST-segment elevation myocardial infarction. Acta CardiolSin. 2019;35(4):360-368.
15.
Verdoia M, Gioscia R, Viola O, et al. Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primarypercutaneous coronary intervention. J Cardiovasc Med.2023;24(9):631-636.
16.
Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct arterypatency on prognosis after acute myocardial infarction. TheSurvival and Ventricular Enlargement Investigators. Circulation.1995;92(5):1101-1109.
17.
Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) beforemechanical reperfusion therapy is an independent determinantof survival in acute myocardial infarction: analysis from theprimary angioplasty in myocardial infarction trials. Circulation.2001;104(6):636-641.
18.
Hashimoto T, Ako J, Nakao K, et al. Pre-procedural thrombolysisin myocardial infarction flow in patients with ST-segmentelevation myocardial infarction. Int Heart J. 2018;59(5):920-925.
19.
Rakowski T, Dudek D, Dziewierz A, et al. Impact of infarct-related artery patency before primary PCI on outcome inpatients with ST-segment elevation myocardial infarction: theHORIZONS-AMI trial. Euro Intervention. 2013;8(11):1307-1314.
20.
Doğan M, Akyel A, Bilgin M, et al. Can Admission Neutrophilto Lymphocyte Ratio Predict Infarct-Related Artery Patency inST-Segment Elevation Myocardial Infarction. Clin Appl ThrombHemost. 2015;21(2):172-176.
21.
Maden O, Kacmaz F, Selcuk MT, et al. Relationship of admissionhaematological indices with infarct-related artery patencyin patients with acute ST-segment elevation myocardialinfarction treated with primary angioplasty. Coron Artery Dis.2007;18(8):639-644.
22.
Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Networkon Atherothrombosis. Inflammation in atherosclerosis: frompathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129-2138.
23.
Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O.Neutrophils as regulators of cardiovascular inflammation. NatRev Cardiol. 2020;17(6):327-340.
24.
Pircher J, Czermak T, Ehrlich A, et al. Cathelicidins primeplatelets to mediate arterial thrombosis and tissue inflammation.Nat Commun. 2018;9(1):1523.
25.
Ganjali S, Momtazi AA, Banach M, Kovanen PT, Stein EA,Sahebkar A. HDL abnormalities in familial hypercholesterolemia:Focus on biological functions. Prog Lipid Res. 2017;67:16-26.
26.
Ozkan E, Erdogan A, Karagoz A, Tanboğa IH. Comparison ofsystemic immune-inflammation index and naples prognosticscore for prediction coronary artery severity patients undergoingcoronary computed tomographic angiography. Angiology.2023;33197231170979.